Targeting type 2 inflammation in bullous pemphigoid (BP): dupilumab as game changer opens new avenues.
Options
BORIS DOI
Date of Publication
December 6, 2024
Publication Type
Article
Division/Institute
Author
Subject(s)
Series
British Journal of Dermatology
ISSN or ISBN (if monograph)
1365-2133
0007-0963
Publisher
Oxford University Press
Language
English
Publisher DOI
PubMed ID
39657119
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| ljae465.pdf | text | Adobe PDF | 135.61 KB | accepted |